SAMSARA THERAPEUTICS Trademark

Trademark Overview

On Wednesday, September 12, 2018, a trademark application was filed for SAMSARA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the SAMSARA THERAPEUTICS trademark a serial number of 88113778. The federal status of this trademark filing is REGISTERED as of Tuesday, January 26, 2021. This trademark is owned by Samsara Therapeutics Inc.. The SAMSARA THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical agents affecting metabolism; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of age-related diseases; Pharmaceuticals, namely, anti-infectives; Anti-diabetic pharmaceuticals; Antibacterial pharmaceuticals; Cardiovascular pharmaceuticals

Pharmaceutical products development; Pharmaceutical research and development; Conducting early evaluations in the field of new pharmaceuticals; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research on the subject of pharmaceuticals
samsara therapeutics

General Information

Serial Number88113778
Word MarkSAMSARA THERAPEUTICS
Filing DateWednesday, September 12, 2018
Status700 - REGISTERED
Status DateTuesday, January 26, 2021
Registration Number6253986
Registration DateTuesday, January 26, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 10, 2020

Trademark Statements

Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesPharmaceutical agents affecting metabolism; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of age-related diseases; Pharmaceuticals, namely, anti-infectives; Anti-diabetic pharmaceuticals; Antibacterial pharmaceuticals; Cardiovascular pharmaceuticals
Goods and ServicesPharmaceutical products development; Pharmaceutical research and development; Conducting early evaluations in the field of new pharmaceuticals; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research on the subject of pharmaceuticals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 19, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 19, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSamsara Therapeutics Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLewes, DE 19958
Party NameSamsara Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLewes, DE 19958
Party NameSamsara Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLewes, DE 19958

Trademark Events

Event DateEvent Description
Tuesday, January 26, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, November 10, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 10, 2020PUBLISHED FOR OPPOSITION
Wednesday, October 21, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 5, 2020LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, September 26, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 25, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 25, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 23, 2020TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, September 9, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, September 9, 2020LETTER OF SUSPENSION E-MAILED
Wednesday, September 9, 2020SUSPENSION LETTER WRITTEN
Tuesday, July 28, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 28, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 22, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 22, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 22, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 22, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 21, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 21, 2020NON-FINAL ACTION E-MAILED
Tuesday, July 21, 2020NON-FINAL ACTION WRITTEN
Friday, July 17, 2020PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, May 26, 2020ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Thursday, May 14, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 7, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 7, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, April 5, 2020NOTICE OF REVIVAL - E-MAILED
Friday, April 3, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 3, 2020PETITION TO REVIVE-GRANTED
Friday, April 3, 2020TEAS PETITION TO REVIVE RECEIVED
Wednesday, February 26, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 26, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 26, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 3, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Saturday, February 1, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, July 15, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 15, 2019NON-FINAL ACTION E-MAILED
Monday, July 15, 2019NON-FINAL ACTION WRITTEN
Monday, June 10, 2019LETTER OF PROTEST EVIDENCE FORWARDED
Thursday, March 14, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, March 14, 2019LETTER OF SUSPENSION E-MAILED
Thursday, March 14, 2019SUSPENSION LETTER WRITTEN
Friday, March 8, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 8, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 1, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, February 22, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, February 22, 2019LETTER OF SUSPENSION E-MAILED
Friday, February 22, 2019SUSPENSION LETTER WRITTEN
Wednesday, February 13, 2019EXAMINER'S AMENDMENT ENTERED
Wednesday, February 13, 2019ASSIGNED TO LIE
Wednesday, February 13, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, February 13, 2019EXAMINERS AMENDMENT E-MAILED
Wednesday, February 13, 2019EXAMINERS AMENDMENT -WRITTEN
Saturday, December 29, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, December 29, 2018NON-FINAL ACTION E-MAILED
Saturday, December 29, 2018NON-FINAL ACTION WRITTEN
Friday, December 21, 2018ASSIGNED TO EXAMINER
Wednesday, September 19, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, September 15, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

therapeutics samsara pharmaceuticals pharmaceutical research development diseases treatment related preparations anti products